abstract |
The present invention is useful as an antagonist of the CGRP receptor and is useful for the treatment or prevention of diseases involving CGRP such as headache, migraine and cluster headache: Wherein the variables A 1 , A 2 , B, J, K, m, n, R 4 , R 5a , R 5b and R 5c are as defined in the specification. The present invention also relates to pharmaceutical compositions containing these compounds and the use of these compounds and compositions in the prevention or treatment of the aforementioned diseases in which CGRP is involved. |